FDA Inspection 1154980 — Medtronic Spinal and Biologics New York Distribution Center
The FDA completed an inspection of Medtronic Spinal and Biologics New York Distribution Center on August 18, 2021 in Swedesboro, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 18, 2021
- Fiscal Year
- 2021
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Swedesboro, NJ (United States)